中国之声——移植物抗宿主病靶向新药的中国实践和探索

采用CD25单抗替代短程甲氨蝶呤在单倍体造血干细胞移植中预防GVHD的疗效比较

致辞

Advancements in GVHD treatment：Emerging drugs and therapeutic strategies

中国造血干细胞移植及新型疗法融合与创新——基于“GRAFT”的初步探索

aGVHD的治疗进展

cGVHD的治疗进展

造血干细胞移植治疗成人ALL——现状与展望

恶性血液病移植复发防治进展

造血干细胞移植CMV防治策略

Optimizing Stem Cell Infusion Timing in the Prevention of Acute Graft versus Host Disease

Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Combined low-dose TBI, IVIg, and DEX during preconditioning for desensitization of high DSA in MMUD and Haplo-HSCT: ensuring stem cell implantation without compromising graft outcome

Decitabine combined with idarubicin in modified busulfan/cyclophosphamide conditioning regimen improves outcome in patients with advanced myelodysplastic syndrome: a prospective multicenter clinical cohort study

Expression of VISTA regulated via IFN-γ governs endogenous T cell function and exhibits correlation with the efficacy of CD19 CAR-T cell treated B-malignant mice

CCCG-ALL-2015方案异基因造血干细胞移植多中心回顾性临床研究

Factors associated with chronic graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation --- a single-center, prospective study

含地西他滨的强化预处理与标准清髓预处理用于成人KMT2A重排急性白血病异基因造血干细胞移植的有效性与安全性研究

不同临床生物学特征对接受异基因造血干细胞移植的NPM1突变的急性髓系白血病患者预后的影响

WT1 Gene Mutations Impact Post-Transplant Relapse in Myelodysplastic Syndrome with Excess Blasts 2 Patients

造血干细胞移植后CMV特异性T细胞在来特莫韦预防中的重建特征

回输采集物成分对恶性血液病异基因造血干细胞移植预后的影响

不同剂量抗胸腺细胞球蛋白在地中海贫血同胞全相合造血干细胞移植的临床研究